Rosana Correa Silva Azevedo

Rosana Correa Silva Azevedo

Auto-generated profile, based on publicly available information

Rosana Correa Silva Azevedo

Departamento de Clínica Médica, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2020 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
DTDaniela Oliveira de Lima Taranto
Daniela Oliveira de Lima Taranto
TGThais Cristine Moura Guimarães
Thais Cristine Moura Guimarães
CCClaudia A. Couto
Claudia A. Couto
ACAna Lúcia Cândido
Ana Lúcia Cândido
RARosana Correa Silva Azevedo
Rosana Correa Silva Azevedo
LFLuciana C. Faria
Luciana C. Faria
Polycystic ovary syndrome (PCOS) is a recognized risk factor for nonalcoholic fatty liver disease (NAFLD). The aims of this study were to investigate the prevalence and factors associated with NAFLD in women with PCOS and evaluate noninvasive indices of hepatic fibrosis in patients with PCOS and NAFLD. Patients with PCOS (n = 87) and women without PCOS (n = 40; controls) were included. NAFLD was diagnosed by abdominal ultrasonography after exclusion of alcohol consumption and viral or autoimmune liver disease. Anthropometric, clinical and metabolic variables, homeostasis model assessment of insulin resistance (HOMA-IR) index, lipid accumulation product (LAP), FIB-4 index, NAFLD score, and transient elastography (TE; FibroScan) were obtained in subsets of patients with PCOS and NAFLD. A total of 87 patients with PCOS were included (mean age: 34.4 ± 5.7 years, mean body mass index [BMI]: 34.7 ± 4.7 kg/m 2 ). NAFLD was present in 67 (77.0%) patients with PCOS versus 21 of 40 (52.5%) controls (p = 0.005). Women with PCOS and liver steatosis, compared with their NAFLD-free counterparts, had higher values of BMI, waist circumference, triglycerides, total cholesterol, alanine and aspartate aminotransferases, and γ-glutamyltransferase, along with higher frequencies of obesity, metabolic syndrome, and insulin resistance. NAFLD was independently associated with waist circumference, serum triglycerides, and alanine aminotransferase levels. The FIB-4 index was not compatible with advanced fibrosis in any of the evaluated patients, while NAFLD score and TE were compatible with advanced liver fibrosis in 1 of 26 (3.8%) and 3 of 25 (12%) patients, respectively. Women with PCOS had a high risk of NAFLD, and a combination of both was associated with central obesity, dyslipidemia, insulin resistance, and metabolic syndrome. Noninvasive methods suggested low rates of severe hepatic fibrosis in Brazilian women with PCOS. Arch Endocrinol Metab. 2020;64(3):235-42.

5 October 2009 in Mycoses
Verified
Journal Article
Closed access
PDF file
TFTeresa Cristina Abreu Ferrari
Teresa Cristina Abreu Ferrari
JSJoão Marcos A. Soares
João Marcos A. Soares
JSJosé Maria P. Salles
José Maria P. Salles
JHJúnia S. Handam
Júnia S. Handam
RARosana C. S. Azevedo
Rosana C. S. Azevedo
LFLuciana C. Faria
Luciana C. Faria

1 January 2025 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
RDRachel C. Damasceno
Rachel C. Damasceno
FOFlávia R. Oliveira
Flávia R. Oliveira
ACAna Lúcia Cândido
Ana Lúcia Cândido
KBKarina Braga Borges
Karina Braga Borges
MBMariana F. Bizzi
Mariana F. Bizzi
FRFernando M Reis
Fernando M Reis
Introduction: Oxyntomodulin (OXM) is a polypeptide hormone of the incretin family, which binds to the glucagon-like peptide 1 receptor, contributing to a reduction in caloric intake, an increase in energy expenditure, and weight loss in obese individuals. Polycystic ovary syndrome (PCOS) is a multifactorial condition characterized by reproductive and metabolic dysfunctions, with a high prevalence among overweight and obese women. This study aimed to investigate the correlation between clinical, anthropometric, endocrine, and metabolic variables and plasma OXM levels in [...] ABSTRACT Introduction: Oxyntomodulin (OXM) is a polypeptide hormone of the incretin family, which binds to the glucagon-like peptide 1 receptor, contributing to a reduction in caloric intake, an increase in energy expenditure, and weight loss in obese individuals. Polycystic ovary syndrome (PCOS) is a multifactorial condition characterized by reproductive and metabolic dysfunctions, with a high prevalence among overweight and obese women. This study aimed to investigate the correlation between clinical, anthropometric, endocrine, and metabolic variables and plasma OXM levels in